Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal.
Saved in:
| Title: | Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal. |
|---|---|
| Authors: | D'Onofrio G; Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut.; Department of Chronic Disease Epidemiology, School of Public Health, Yale University, New Haven, Connecticut., Herring AA; Department of Emergency Medicine, Highland General Hospital-Alameda Health System, Oakland, California.; Department of Addiction Medicine, Highland General Hospital-Alameda Health System, Oakland, California.; Department of Emergency Medicine, University of California, San Francisco., Perrone J; Department of Emergency Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Hawk K; Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut.; Department of Chronic Disease Epidemiology, School of Public Health, Yale University, New Haven, Connecticut., Samuels EA; Department of Emergency Medicine, David Geffen School of Medicine at the University of California, Los Angeles.; Department of Emergency Medicine, the Warren Alpert Medical School, Brown University, Providence, Rhode Island., Cowan E; Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Anderson E; Department of Emergency Medicine, Highland General Hospital-Alameda Health System, Oakland, California.; Department of Addiction Medicine, Highland General Hospital-Alameda Health System, Oakland, California., McCormack R; Ronald O. Perelman Department of Emergency Medicine at New York University Langone Health, New York., Huntley K; Center for Clinical Trials, Clinical Trials Network, National Institute on Drug Abuse, Rockville, Maryland., Owens P; Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut., Martel S; Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut., Schactman M; The Emmes Company, LLC, Rockville, Maryland., Lofwall MR; Department of Behavioral Science, University of Kentucky College of Medicine, Lexington.; Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington., Walsh SL; Department of Behavioral Science, University of Kentucky College of Medicine, Lexington.; Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington., Dziura J; Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut., Fiellin DA; Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut.; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut. |
| Source: | JAMA network open [JAMA Netw Open] 2024 Jul 01; Vol. 7 (7), pp. e2420702. Date of Electronic Publication: 2024 Jul 01. |
| Publication Type: | Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2574-3805 |
|---|---|
| DOI: | 10.1001/jamanetworkopen.2024.20702 |
